Galectin Therapeutics Inc. (GALT)

NASDAQ: GALT · IEX Real-Time Price · USD

3.290

-0.090 (-2.66%)

At close: Apr 24, 2024, 4:00 PM

3.300

+0.010 (0.30%)

After-hours: Apr 24, 2024, 7:32 PM EDT

Galectin Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Net Income	-44.81	-38.87	-30.7	-23.6	-20.18	-15.05	-17.47	-22.35	-21.12	-16.96	Upgrade
Depreciation & Amortization	0.03	0.03	0.04	0.04	0.04	0	0	0.01	0.01	0.01	Upgrade
Share-Based Compensation	2.26	2.87	2.08	1.8	1.68	4.46	1.13	2.48	3.4	4.07	Upgrade
Other Operating Activities	9.43	4.82	4.1	1.03	0.73	-0.74	-0.79	2.54	-0.36	-0.72	Upgrade
Operating Cash Flow	-32.97	-31.06	-24.31	-20.6	-10.85	-10.18	-15.89	-16.41	-16.98	-12.43	Upgrade
Acquisitions	0	0	0	0	0	0	0	0	0	-0.4	Upgrade
Investing Cash Flow	0	0	0	0	0	0	0	0	0	-0.4	Upgrade
Share Issuance / Repurchase	10.03	0	6.81	0.26	50.47	15.38	3.58	5.93	13.7	31.47	Upgrade
Debt Issued / Paid	30	10	30	0	0	0	0	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-0.39	-	-	-	-	-	Upgrade
Financing Cash Flow	40.03	10	36.81	0.26	50.08	15.38	3.58	5.93	13.7	31.47	Upgrade
Net Cash Flow	7.07	-21.06	12.51	-20.34	39.23	5.2	-12.31	-10.48	-3.28	18.64	Upgrade
Free Cash Flow	-32.97	-31.06	-24.31	-20.6	-10.85	-10.18	-15.89	-16.41	-16.98	-12.43	Upgrade
Free Cash Flow Per Share	-0.55	-0.52	-0.41	-0.36	-0.21	-0.26	-0.45	-0.56	-0.70	-0.57	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).